Dynavax Technologies Corp. (DE:DYF1)
FRANKFURT:DYF1
Holding DE:DYF1?
Track your performance easily

Dynavax (DYF1) Income Statement

0 Followers

Dynavax Income Statement

Last quarter (Q3 2024), Dynavax's total revenue was $80.63M, an increase of 15.99% from the same quarter last year. In Q3, Dynavax's net income was $17.59M. See Dynavax’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 260.81M$ 232.28M$ 722.68M$ 439.44M$ 46.55M$ 35.22M
Cost of Revenue
$ 44.72M$ 50.17M$ 262.15M$ 173.57M$ 13.91M$ 19.39M
Gross Profit
$ 216.09M$ 182.12M$ 460.53M$ 265.87M$ 32.64M$ 15.83M
Operating Expense
$ 227.07M$ 207.83M$ 178.01M$ 132.38M$ 107.86M$ 137.32M
Operating Income
$ -10.98M$ -37.03M$ 283.52M$ 134.49M$ -68.37M$ -134.84M
Net Non Operating Interest Income Expense
$ 32.52M$ 25.24M$ 1.18M$ -11.04M$ -17.80M$ -13.61M
Other Income Expense
$ 1.67M$ -3.89M$ 10.60M$ 52.66M$ -10.08M$ 6.77M
Pretax Income
$ 24.22M$ -4.37M$ 294.30M$ 77.52M$ -75.24M$ -152.60M
Tax Provision
$ 3.75M$ 2.02M$ 1.14M$ 808.00K$ -3.19M$ -3.15M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 20.48M$ -6.39M$ 292.87M$ 72.14M$ -75.24M$ -155.87M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 271.79M$ 258.00M$ 440.16M$ 305.96M$ 119.27M$ 156.71M
Net Income From Continuing And Discontinued Operation
$ 20.48M$ -6.39M$ 293.16M$ 76.71M$ -75.24M$ -152.60M
Normalized Income
$ 34.38M-----
Interest Expense
------
EBIT
$ 28.59M$ 2.39M$ 301.03M$ 88.70M$ -56.18M$ -135.62M
EBITDA
$ 39.34M$ 9.67M$ 307.70M$ 95.75M$ -46.84M$ -115.59M
Currency in USD

Dynavax Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis